Medytox, a biopharmaceutical company, announced that its hyaluronic acid filler 'Neuramis' obtained permission in in Brazil, the Philippines, Malaysia and Saudi Arabia.
Medytox's hyaluronic acid filler 'Neuramis' has recently entered 44 countries around the world by obtaining item permission in Brazil and the Philippines. In particular, it plans to maximize synergy in the aesthetic field based on the awareness of 'Medytoxin', which has achieved a 40% market share in the Brazilian market in 4 years after its launch. It is also planning to obtain marketing approval in Taiwan, Mexico, and El Salvador within this year, and plans to take a leap forward as a global filler brand by actively utilizing the European CE certification possessed by the three types of Neuramis series.
See this product: https://www.koreabeautytech.com/ja/search?type=product%2Cpage%2Carticle&q=neuramis
